Swiss National Bank Guardant Health, Inc. Transaction History

Swiss National Bank

$167 Billion
Q3 2025

A detailed history of Swiss National Bank transactions in Guardant Health, Inc. stock. As of the latest transaction made, Swiss National Bank holds 216,100 shares of GH stock, worth $20.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

216,100

Previous 239,300 9.69%

Holding current value

$20.4 Million

Previous $10.2 Million 32.44%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$40.98 - $67.42 $950,735 - $1.56 Million	-23,200 Reduced 9.69%	216,100 $13.5 Million
Q1 2025 May 12, 2025	SELL	$31.77 - $49.94 $82,602 - $129,844	-2,600 Reduced 1.07%	239,300 $10.2 Million
Q4 2024 Feb 10, 2025	BUY	$20.2 - $38.11 $50,500 - $95,275	2,500 Added 1.04%	241,900 $7.39 Million
Q2 2024 Aug 08, 2024	BUY	$16.07 - $31.84 $188,019 - $372,528	11,700 Added 5.14%	239,400 $6.91 Million
Q1 2024 May 07, 2024	BUY	$17.13 - $26.91 $125,049 - $196,443	7,300 Added 3.31%	227,700 $4.7 Million

Q4 2023 Feb 06, 2024	SELL	$21.58 - $29.5 $524,394 - $716,850	-24,300 Reduced 9.93%	220,400 $5.96 Million
Q3 2023 Nov 08, 2023	BUY	$25.8 - $39.97 $167,700 - $259,805	6,500 Added 2.73%	244,700 $7.25 Million
Q2 2023 Aug 09, 2023	BUY	$20.94 - $38.01 $588,414 - $1.07 Million	28,100 Added 13.37%	238,200 $8.53 Million
Q1 2023 May 10, 2023	SELL	$22.92 - $33.76 $275,040 - $405,120	-12,000 Reduced 5.4%	210,100 $4.92 Million
Q4 2022 Feb 08, 2023	BUY	$25.44 - $59.78 $117,024 - $274,988	4,600 Added 2.11%	222,100 $6.04 Million
Q3 2022 Nov 09, 2022	BUY	$43.66 - $61.0 $65,489 - $91,500	1,500 Added 0.69%	217,500 $11.7 Million
Q2 2022 Aug 09, 2022	BUY	$28.82 - $77.35 $337,194 - $904,994	11,700 Added 5.73%	216,000 $8.71 Million
Q1 2022 May 09, 2022	BUY	$48.25 - $100.49 $714,100 - $1.49 Million	14,800 Added 7.81%	204,300 $13.5 Million
Q4 2021 Feb 08, 2022	SELL	$88.71 - $120.43 $35,484 - $48,172	-400 Reduced 0.21%	189,500 $19 Million
Q3 2021 Nov 08, 2021	BUY	$98.77 - $132.17 $167,909 - $224,688	1,700 Added 0.9%	189,900 $23.7 Million
Q2 2021 Aug 06, 2021	BUY	$109.77 - $165.68 $1.86 Million - $2.8 Million	16,900 Added 9.87%	188,200 $23.4 Million
Q1 2021 May 07, 2021	BUY	$127.04 - $179.1 $343,008 - $483,570	2,700 Added 1.6%	171,300 $26.1 Million
Q4 2020 Feb 05, 2021	BUY	$99.96 - $135.93 $4 Million - $5.44 Million	40,000 Added 31.1%	168,600 $21.7 Million
Q3 2020 Nov 09, 2020	BUY	$80.32 - $111.8 $192,767 - $268,320	2,400 Added 1.9%	128,600 $14.4 Million
Q2 2020 Aug 05, 2020	BUY	$60.49 - $97.5 $3.22 Million - $5.2 Million	53,300 Added 73.11%	126,200 $10.2 Million
Q1 2020 May 08, 2020	BUY	$59.04 - $88.81 $100,368 - $150,977	1,700 Added 2.39%	72,900 $5.07 Million
Q4 2019 Feb 06, 2020	BUY	$59.49 - $82.78 $154,674 - $215,228	2,600 Added 3.79%	71,200 $5.56 Million
Q3 2019 Nov 12, 2019	BUY	$62.59 - $110.3 $2.3 Million - $4.05 Million	36,700 Added 115.05%	68,600 $4.38 Million
Q2 2019 Aug 02, 2019	BUY	$63.94 - $91.11 $2.04 Million - $2.91 Million	31,900 New	31,900 $2.75 Million

Others Institutions Holding GH

# of Institutions

467

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Guardant Health, Inc. Transaction History